Physician profile
Nancy D Dover
NPI 1194775411
$1,528.31
in general payments reported to CMS, 2019-2025
18 companies · $399 in 2025
The $399 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.83 · 2022: $231 · 2023: $385 · 2024: $497 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,281.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $249.98 | 2023-2024 | Arexvy |
| Mimedx Group, INC. | $193.70 | 2024-2025 | |
| Stryker Corporation | $161.82 | 2023-2024 | Infinity Adaptis, 1788, Mako |
| Biohaven Pharmaceutical Holding Company LTD. | $125.01 | 2022 | |
| Gilead Sciences, INC. | $92.49 | 2025 | Livdelzi |
| Bayer Healthcare Pharmaceuticals INC. | $83.07 | 2022 | |
| Corcept Therapeutics | $80.16 | 2025 | Korlym |
| Abbvie INC. | $75.03 | 2024 | |
| Phathom Pharmaceuticals, INC. | $70.93 | 2024 | Voquezna |
| Axsome Therapeutics, INC. | $69.43 | 2025 | Auvelity |
| Genzyme Corporation | $66.16 | 2025 | |
| Dexcom, INC. | $66.06 | 2023 | Dexcom G7 Gss (161) |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.06 | 2023 | Jardiance |
| Amgen INC. | $40.63 | 2023 | Repatha |
| Sumitomo Pharma America, INC. | $39.15 | 2023 | Gemtesa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Masimo Corporation | $23.12 | 2022 | |
| Abbott Laboratories | $22.68 | 2023 | Alere Determine Hiv1/2 Ag/Ab Combo |
| Hologic INC | $15.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Dover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.